BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 38336987)

  • 1. Copper Metabolism and Cuproptosis: Molecular Mechanisms and Therapeutic Perspectives in Neurodegenerative Diseases.
    Ban XX; Wan H; Wan XX; Tan YT; Hu XM; Ban HX; Chen XY; Huang K; Zhang Q; Xiong K
    Curr Med Sci; 2024 Feb; 44(1):28-50. PubMed ID: 38336987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper homeostasis and cuproptosis in health and disease.
    Chen L; Min J; Wang F
    Signal Transduct Target Ther; 2022 Nov; 7(1):378. PubMed ID: 36414625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper metabolism and cuproptosis in human malignancies: Unraveling the complex interplay for therapeutic insights.
    Abdullah KM; Kaushal JB; Takkar S; Sharma G; Alsafwani ZW; Pothuraju R; Batra SK; Siddiqui JA
    Heliyon; 2024 Mar; 10(5):e27496. PubMed ID: 38486750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles and mechanisms of copper homeostasis and cuproptosis in osteoarticular diseases.
    Han J; Luo J; Wang C; Kapilevich L; Zhang XA
    Biomed Pharmacother; 2024 May; 174():116570. PubMed ID: 38599063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper homeostasis and cuproptosis in cancer immunity and therapy.
    Liu WQ; Lin WR; Yan L; Xu WH; Yang J
    Immunol Rev; 2024 Jan; 321(1):211-227. PubMed ID: 37715546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of cuproptosis in Parkinson's disease.
    Huang M; Zhang Y; Liu X
    Ageing Res Rev; 2024 Mar; 95():102214. PubMed ID: 38311254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease.
    Wang D; Tian Z; Zhang P; Zhen L; Meng Q; Sun B; Xu X; Jia T; Li S
    Biomed Pharmacother; 2023 Jul; 163():114830. PubMed ID: 37150036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cuproptosis-a potential target for the treatment of osteoporosis.
    Li D; Gao Z; Li Q; Liu X; Liu H
    Front Endocrinol (Lausanne); 2023; 14():1135181. PubMed ID: 37214253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cuproptosis: unveiling a new frontier in cancer biology and therapeutics.
    Feng Y; Yang Z; Wang J; Zhao H
    Cell Commun Signal; 2024 May; 22(1):249. PubMed ID: 38693584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper homeostasis and cuproptosis in mitochondria.
    Tian Z; Jiang S; Zhou J; Zhang W
    Life Sci; 2023 Dec; 334():122223. PubMed ID: 38084674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein lipoylation: mitochondria, cuproptosis, and beyond.
    Lin CH; Chin Y; Zhou M; Sobol RW; Hung MC; Tan M
    Trends Biochem Sci; 2024 May; ():. PubMed ID: 38714376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cuproptosis as the new kryptonite of cancer: a copper-dependent novel cell death mechanism with promising implications for the treatment of hepatocellular carcinoma.
    Ozkan E; Bakar-Ates F
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17663-17670. PubMed ID: 37843555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cuproptosis: Mechanism, role, and advances in urological malignancies.
    Wu J; He J; Liu Z; Zhu X; Li Z; Chen A; Lu J
    Med Res Rev; 2024 Jul; 44(4):1662-1682. PubMed ID: 38299968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper homeostasis and cuproptosis in atherosclerosis: metabolism, mechanisms and potential therapeutic strategies.
    Yang S; Li Y; Zhou L; Wang X; Liu L; Wu M
    Cell Death Discov; 2024 Jan; 10(1):25. PubMed ID: 38218941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring cuproptosis as a mechanism and potential intervention target in cardiovascular diseases.
    Yang Y; Feng Q; Luan Y; Liu H; Jiao Y; Hao H; Yu B; Luan Y; Ren K
    Front Pharmacol; 2023; 14():1229297. PubMed ID: 37637426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of cuproptosis and its relevance to distinct diseases.
    Lou QM; Lai FF; Li JW; Mao KJ; Wan HT; He Y
    Apoptosis; 2024 Jun; ():. PubMed ID: 38824478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cope with copper: From molecular mechanisms of cuproptosis to copper-related kidney diseases.
    Zou Y; Wu S; Xu X; Tan X; Yang S; Chen T; Zhang J; Li S; Li W; Wang F
    Int Immunopharmacol; 2024 May; 133():112075. PubMed ID: 38663316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting cuproplasia and cuproptosis in cancer.
    Tang D; Kroemer G; Kang R
    Nat Rev Clin Oncol; 2024 May; 21(5):370-388. PubMed ID: 38486054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper homeostasis and cuproptosis in gynecological disorders: Pathogenic insights and therapeutic implications.
    Lin Y; Yuan M; Wang G
    J Trace Elem Med Biol; 2024 Jul; 84():127436. PubMed ID: 38547725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper's dual role: unravelling the link between copper homeostasis, cuproptosis, and cardiovascular diseases.
    Parsanathan R
    Hypertens Res; 2024 May; 47(5):1440-1442. PubMed ID: 38467792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.